Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 206

1.

Impacts of a changing earth on microbial dynamics and human health risks in the continuum between beach water and sand.

Weiskerger CJ, Brandão J, Ahmed W, Aslan A, Avolio L, Badgley BD, Boehm AB, Edge TA, Fleisher JM, Heaney CD, Jordao L, Kinzelman JL, Klaus JS, Kleinheinz GT, Meriläinen P, Nshimyimana JP, Phanikumar MS, Piggot AM, Pitkänen T, Robinson C, Sadowsky MJ, Staley C, Staley ZR, Symonds EM, Vogel LJ, Yamahara KM, Whitman RL, Solo-Gabriele HM, Harwood VJ.

Water Res. 2019 Jul 3;162:456-470. doi: 10.1016/j.watres.2019.07.006. [Epub ahead of print] Review.

PMID:
31301475
2.

Pepper mild mottle virus: Agricultural menace turned effective tool for microbial water quality monitoring and assessing (waste)water treatment technologies.

Symonds EM, Rosario K, Breitbart M.

PLoS Pathog. 2019 Apr 18;15(4):e1007639. doi: 10.1371/journal.ppat.1007639. eCollection 2019 Apr. No abstract available.

3.

Predicting culturable enterococci exceedances at Escambron Beach, San Juan, Puerto Rico using satellite remote sensing and artificial neural networks.

Laureano-Rosario AE, Duncan AP, Symonds EM, Savic DA, Muller-Karger FE.

J Water Health. 2019 Feb;17(1):137-148. doi: 10.2166/wh.2018.128.

PMID:
30758310
4.

Pepper mild mottle virus: A plant pathogen with a greater purpose in (waste)water treatment development and public health management.

Symonds EM, Nguyen KH, Harwood VJ, Breitbart M.

Water Res. 2018 Nov 1;144:1-12. doi: 10.1016/j.watres.2018.06.066. Epub 2018 Jun 30. Review.

PMID:
30005176
5.

Environmental Factors Correlated with Culturable Enterococci Concentrations in Tropical Recreational Waters: A Case Study in Escambron Beach, San Juan, Puerto Rico.

Laureano-Rosario AE, Symonds EM, Rueda-Roa D, Otis D, Muller-Karger FE.

Int J Environ Res Public Health. 2017 Dec 19;14(12). pii: E1602. doi: 10.3390/ijerph14121602.

6.

Microbial source tracking in shellfish harvesting waters in the Gulf of Nicoya, Costa Rica.

Symonds EM, Young S, Verbyla ME, McQuaig-Ulrich SM, Ross E, Jiménez JA, Harwood VJ, Breitbart M.

Water Res. 2017 Mar 15;111:177-184. doi: 10.1016/j.watres.2017.01.004. Epub 2017 Jan 3.

PMID:
28086114
7.

Faecal pollution along the southeastern coast of Florida and insight into the use of pepper mild mottle virus as an indicator.

Symonds EM, Sinigalliano C, Gidley M, Ahmed W, McQuaig-Ulrich SM, Breitbart M.

J Appl Microbiol. 2016 Nov;121(5):1469-1481. doi: 10.1111/jam.13252.

PMID:
27501154
8.

Managing Microbial Risks from Indirect Wastewater Reuse for Irrigation in Urbanizing Watersheds.

Verbyla ME, Symonds EM, Kafle RC, Cairns MR, Iriarte M, Mercado Guzmán A, Coronado O, Breitbart M, Ledo C, Mihelcic JR.

Environ Sci Technol. 2016 Jul 5;50(13):6803-13. doi: 10.1021/acs.est.5b05398. Epub 2016 Apr 6.

PMID:
26992352
9.

Reduction of nutrients, microbes, and personal care products in domestic wastewater by a benchtop electrocoagulation unit.

Symonds EM, Cook MM, McQuaig SM, Ulrich RM, Schenck RO, Lukasik JO, Van Vleet ES, Breitbart M.

Sci Rep. 2015 Mar 23;5:9380. doi: 10.1038/srep09380.

10.

A case study of enteric virus removal and insights into the associated risk of water reuse for two wastewater treatment pond systems in Bolivia.

Symonds EM, Verbyla ME, Lukasik JO, Kafle RC, Breitbart M, Mihelcic JR.

Water Res. 2014 Nov 15;65:257-70. doi: 10.1016/j.watres.2014.07.032. Epub 2014 Aug 2.

PMID:
25129566
11.

Diversity and distribution of single-stranded DNA phages in the North Atlantic Ocean.

Tucker KP, Parsons R, Symonds EM, Breitbart M.

ISME J. 2011 May;5(5):822-30. doi: 10.1038/ismej.2010.188. Epub 2010 Dec 2.

12.

Pepper mild mottle virus as an indicator of fecal pollution.

Rosario K, Symonds EM, Sinigalliano C, Stewart J, Breitbart M.

Appl Environ Microbiol. 2009 Nov;75(22):7261-7. doi: 10.1128/AEM.00410-09. Epub 2009 Sep 18.

13.

Eukaryotic viruses in wastewater samples from the United States.

Symonds EM, Griffin DW, Breitbart M.

Appl Environ Microbiol. 2009 Mar;75(5):1402-9. doi: 10.1128/AEM.01899-08. Epub 2009 Jan 5.

14.

Is grandmultiparity a significant risk factor in this new millennium?

Nordin NM, Fen CK, Isa S, Symonds EM.

Malays J Med Sci. 2006 Jul;13(2):52-60.

15.

The research quality framework.

Symonds EM.

Med J Aust. 2006 Jun 19;184(12):647. No abstract available.

PMID:
16803454
16.

Audit of birth defects in 34,109 deliveries in a tertiary referral center.

Noraihan MN, See MH, Raja R, Baskaran TP, Symonds EM.

Med J Malaysia. 2005 Oct;60(4):460-8.

17.

Comparison of maternal-fetal outcomes in gestational diabetes and lesser degrees of glucose intolerance.

Nordin NM, Wei JW, Naing NN, Symonds EM.

J Obstet Gynaecol Res. 2006 Feb;32(1):107-14.

PMID:
16445535
18.

Five futures for academic medicine: future of academic medicine looks bleak.

Symonds EM, Bell P, Banatvala J.

BMJ. 2005 Sep 24;331(7518):694. No abstract available.

19.

The research assessment exercise and academic obstetrics and gynaecology.

Symonds EM.

BJOG. 2005 Feb;112(2):129-30. No abstract available.

20.

Delivery of macrosomic babies: management and outcomes of 330 cases.

Lim JH, Tan BC, Jammal AE, Symonds EM.

J Obstet Gynaecol. 2002 Jul;22(4):370-4.

PMID:
12521456
21.

Academic obstetrics and gynaecology in the UK.

Symonds EM.

Baillieres Best Pract Res Clin Obstet Gynaecol. 1999 Sep;13(3):393-9; discussion 399-402.

PMID:
10718723
22.

The impact of the research assessment exercise on the funding of medical schools.

Symonds EM.

J Public Health Med. 1999 Jun;21(2):123-4. No abstract available.

PMID:
10432238
23.

An immunoscintigraphic evaluation of the engineered human monoclonal antibody (hCTMO1) for use in the treatment of ovarian carcinoma.

Davies Q, Perkins AC, Roos JC, Molthoff CF, Verheijen RH, Frier M, Kenemans P, Broadhead T, Sopwith M, Symonds EM.

Br J Obstet Gynaecol. 1999 Jan;106(1):31-7.

PMID:
10426256
24.

Cellular proliferation in the placenta in normal human pregnancy and pregnancy complicated by intrauterine growth restriction.

Smith SC, Price E, Hewitt MJ, Symonds EM, Baker PN.

J Soc Gynecol Investig. 1998 Nov-Dec;5(6):317-23.

PMID:
9824812
25.

Biodistribution of 111In-labelled engineered human antibody CTM01 (hCTM01) in ovarian cancer patients: influence of prior administration of unlabelled hCTM01.

Prinssen HM, Molthoff CF, Verheijen RH, Broadhead TJ, Kenemans P, Roos JC, Davies Q, van Hof AC, Frier M, den Hollander W, Wilhelm AJ, Baker TS, Sopwith M, Symonds EM, Perkins AC.

Cancer Immunol Immunother. 1998 Sep;47(1):39-46.

PMID:
9755877
26.
27.

Increased placental apoptosis in intrauterine growth restriction.

Smith SC, Baker PN, Symonds EM.

Am J Obstet Gynecol. 1997 Dec;177(6):1395-401.

PMID:
9423741
28.

Placental apoptosis in normal human pregnancy.

Smith SC, Baker PN, Symonds EM.

Am J Obstet Gynecol. 1997 Jul;177(1):57-65.

PMID:
9240583
29.

The effect of circulating antigen on the biodistribution of the engineered human antibody hCTM01 in a nude mice model.

Davies Q, Perkins AC, Frier M, Watson S, Lalani E, Symonds EM.

Eur J Nucl Med. 1997 Feb;24(2):206-9.

PMID:
9021120
30.

Biodistribution of (111)indium-labeled engineered human antibody CTMO1 in ovarian cancer patients: influence of protein dose.

van Hof AC, Molthoff CF, Davies Q, Perkins AC, Verheijen RH, Kenemans P, den Hollander W, Wilhelm AJ, Baker TS, Sopwith M, Frier M, Symonds EM, Roos JC.

Cancer Res. 1996 Nov 15;56(22):5179-85.

31.

The potential impact of PR interval analysis of the fetal electrocardiogram (FECG) on intrapartum fetal monitoring.

Reed NN, Mohajer MP, Sahota DS, James DK, Symonds EM.

Eur J Obstet Gynecol Reprod Biol. 1996 Sep;68(1-2):87-92.

PMID:
8886687
32.

Changes in the PR interval--fetal heart rate relationship of the electrocardiogram during fetal compromise in chronically instrumented sheep.

van Wijngaarden WJ, de Haan HH, Sahota DS, James DK, Symonds EM, Hasaart TH.

Am J Obstet Gynecol. 1996 Sep;175(3 Pt 1):548-54.

PMID:
8828412
33.

The fetal electrocardiogram.

van Wijngaarden WJ, James DK, Symonds EM.

Baillieres Clin Obstet Gynaecol. 1996 Jun;10(2):273-94. Review.

PMID:
8836485
34.

Antenatal assessment using the FECG obtained via abdominal electrodes.

Crowe JA, Woolfson MS, Hayes-Gill BR, Peasgood W, Mohd-Ali MA, Huang Y, Herbert J, Huang XB, Harrison A, Gibson NM, Symonds EM, Reed N, Mohajer M.

J Perinat Med. 1996;24(1):43-53. Review.

PMID:
8708930
35.

Hypertension in pregnancy.

Symonds EM.

Arch Dis Child Fetal Neonatal Ed. 1995 Mar;72(2):F139-44. Review. No abstract available.

36.

Fetal monitoring: medical and legal implications for the practitioner.

Symonds EM.

Curr Opin Obstet Gynecol. 1994 Oct;6(5):430-3. Review.

PMID:
7827273
37.

Plymouth randomized control trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases.

Reed NN, Sahota DS, Mohajer MP, Van Wijngaarden W, James DK, Symonds EM.

Am J Obstet Gynecol. 1994 Sep;171(3):867-8. No abstract available.

PMID:
8092245
38.

Neonatal and maternal platelet cytosolic calcium in normotensive and hypertensive pregnancies.

Kilby MD, Broughton Pipkin F, Symonds EM.

Arch Dis Child Fetal Neonatal Ed. 1994 Jul;71(1):F6-10.

39.

Cumulative changes in the fetal electrocardiogram and biochemical indices of fetal hypoxia.

Mohajer MP, Sahota DS, Reed NN, Chang A, Symonds EM, James DK.

Eur J Obstet Gynecol Reprod Biol. 1994 May 31;55(1):63-70.

PMID:
7958143
40.

Neonatal platelet reactivity and serum thromboxane B2 production in whole blood: the effect of maternal low dose aspirin.

Louden KA, Broughton Pipkin F, Heptinstall S, Fox SC, Tuohy P, O'Callaghan C, Mitchell JR, Symonds EM.

Br J Obstet Gynaecol. 1994 Mar;101(3):203-8.

PMID:
8193093
41.

Immunoscintigraphy of ovarian carcinoma using a monoclonal antibody (111In-NCRC48) defining a polymorphic epithelial mucin (PEM) epitope.

Perkins AC, Symonds IM, Pimm MV, Price MR, Wastie ML, Symonds EM.

Nucl Med Commun. 1993 Jul;14(7):578-86.

PMID:
8355918
42.

Platelet cytosolic calcium in human pregnancy complicated by essential hypertension.

Kilby MD, Broughton Pipkin F, Symonds EM.

Am J Obstet Gynecol. 1993 Jul;169(1):141-3.

PMID:
8333441
43.

Changes in platelet intracellular free calcium in normal pregnancy.

Kilby MD, Broughton Pipkin F, Symonds EM.

Br J Obstet Gynaecol. 1993 Apr;100(4):375-9.

PMID:
8494840
44.

Litigation and the cardiotocogram.

Symonds EM.

Br J Obstet Gynaecol. 1993 Mar;100 Suppl 9:8-9. Review.

PMID:
8471570
45.

A randomised placebo controlled trial of labetalol in the treatment of mild to moderate pregnancy induced hypertension.

Pickles CJ, Broughton Pipkin F, Symonds EM.

Br J Obstet Gynaecol. 1992 Dec;99(12):964-8.

PMID:
1477017
46.

Calcium and platelets in normotensive and hypertensive human pregnancy.

Kilby MD, Broughton Pipkin F, Symonds EM.

J Hypertens. 1992 Sep;10(9):997-1003.

PMID:
1328382
47.
48.

A randomized placebo-controlled study of the effect of low dose aspirin on platelet reactivity and serum thromboxane B2 production in non-pregnant women, in normal pregnancy, and in gestational hypertension.

Louden KA, Broughton Pipkin F, Symonds EM, Tuohy P, O'Callaghan C, Heptinstall S, Fox S, Mitchell JR.

Br J Obstet Gynaecol. 1992 May;99(5):371-6.

PMID:
1622907
49.

Subzonal insemination.

Fishel S, Timson J, Faratian B, Symonds EM.

Lancet. 1992 Apr 11;339(8798):932-3. No abstract available.

PMID:
1348325
50.

Longitudinal study of platelet angiotensin II binding in human pregnancy.

Baker PN, Broughton Pipkin F, Symonds EM.

Clin Sci (Lond). 1992 Apr;82(4):377-81.

PMID:
1315647

Supplemental Content

Loading ...
Support Center